Meadow Creek Investment Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Meadow Creek Investment Management’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$153K	Buy	13,272 +3,052	+30%	+$32.1K	﹤0.01%	1108
2019 Q2	$102K	Buy	10,220 +2,492	+32%	+$26.9K	﹤0.01%	1213
2019 Q1	$100K	Hold	7,728	–	–	﹤0.01%	1191
2018 Q4	$117K	Hold	7,728	–	–	﹤0.01%	1117
2018 Q3	$155K	Hold	7,728	–	–	﹤0.01%	1150
2018 Q2	$151K	Hold	7,728	–	–	﹤0.01%	1078
2018 Q1	$156K	Buy	7,728 +1,008	+15%	+$17.1K	﹤0.01%	1075
2017 Q4	$89K	Buy	6,720 +1,512	+29%	+$22.8K	﹤0.01%	1212
2017 Q3	$96K	Buy	5,208 +1,428	+38%	+$26.6K	﹤0.01%	1162
2017 Q2	$69K	Buy	3,780 +1,960	+108%	+$38.8K	﹤0.01%	1191
2017 Q1	$41K	Buy	1,820 +84	+5%	+$2.01K	﹤0.01%	1199
2016 Q4	$60K	Buy	+1,736	New	+$51.9K	﹤0.01%	1075

Other funds holding AMAG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Meadow Creek Investment Management's AMAG Position: Q3 2019 in Review

Meadow Creek Investment Management increased its AMAG Pharmaceuticals (AMAG) stake by 30% in Q3 2019, buying an estimated $32.1K and bringing the position to 13,272 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #1108.

Meadow Creek Investment Management first reported a position in AMAG in Q4 2016 and has held it in 12 quarters since. The position peaked at $156K in Q1 2018. 156 funds tracked by Wall St. Rank hold AMAG as of Q3 2019.

Meadow Creek Investment Management held 13,272 shares of AMAG Pharmaceuticals worth $153K as of Q3 2019.
Meadow Creek Investment Management bought 3,052 AMAG Pharmaceuticals shares in Q3 2019, an estimated $32.1K.
AMAG Pharmaceuticals made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #1108 holding.
Meadow Creek Investment Management first reported a position in AMAG Pharmaceuticals in Q4 2016 and has held it in 12 quarters since.
Meadow Creek Investment Management's AMAG Pharmaceuticals position peaked at $156K in Q1 2018.
156 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.